Peripheral T-Cell lymphoma, NOS
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| HC (1) | CD30 + | Peripheral T-Cell lymphoma, NOS | Brentuximab vedotin, Cyclophosphamide, Doxorubicin, Prednisone |